← Leaderboards
Robert C. Welliver
Heartland Vaccines, Llc
$426,190
Attributed
$426,190
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $267.7K · FY2019–20$500K$375K$250K$125K$0
'19
'20
Funding mix
By agency
NIH$426,190 · 1
By mechanism
R41$426,190 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAerosolizedAerosolsAge-MonthsAnimal ModelAnimalsAntibody ResponseAntibody Titer MeasurementAttenuatedAttenuated Live Virus VaccineAttenuated VaccinesAttenuationBackCellsCessation Of LifeCharacteristicsCollaborationsComplementDepositionDesignDevicesDoseEffectivenessAdjuvant
Grant awards (2)
Development of an M Protein-Deficient Respiratory Syncytial Virus Vaccine for Aerosolized Vaccination of the Lung$158,518
R41 · FY2020 · AI · contact PI
Development of an M Protein-Deficient Respiratory Syncytial Virus Vaccine for Aerosolized Vaccination of the Lung$267,672
R41 · FY2019 · AI · contact PI